...

Tesamorelin 10mg

$129.99

(5.0) (45 customer reviews)

Research Studies:

  • Potent GHRH-analog for stimulating pulsatile growth hormone secretion in somatotroph models
  • Facilitates analysis of GH-mediated lipolytic signaling and visceral adipose metabolic flux
  • Supports investigation into insulin-like growth factor-1 induction and systemic anabolic pathways
  • Useful for probing hypothalamic-pituitary-somatotropic axis regulation in cellular research assays

Quantity:

Free Shipping
Buy Peptides with confidence: Stripe-powered secure checkout and major cards accepted.
Secure payment methods for buying peptides: Visa, MasterCard, AMEX, and more.
Buy Peptides with confidence: Stripe-powered secure checkout and major cards accepted.
Secure payment methods for buying peptides: Visa, MasterCard, AMEX, and more.

FREE Shipping on 

orders over $200

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Description

Tesamorelin 10mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

  • Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
  • Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
  • Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
  • Produced with lot-level traceability to support research documentation and laboratory recordkeeping.

Research Documentation Context

  • Supports compound characterization in controlled laboratory settings.
  • Provides batch-specific identity and purity documentation for research review.
  • Allows lot-level traceability across laboratory documentation workflows.
  • Supports comparison of product labeling, analytical documentation, and storage information during research planning.
  • Supports analytical review of peptide research materials within a strictly laboratory-focused context.

Specifications and Documentation

  • Certificate of Analysis: Available with batch-specific documentation where applicable.
  • Material Safety Data Sheet: Coming Soon.
  • Handling and Storage Instructions: Coming Soon.
  • Product Form: Lyophilized powder.
  • Purity Specification: ≥99% purity.
  • Intended Use: Laboratory research use only.

Tesamorelin 10mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

Additional information

CAS No.

218949-48-5

Purity

≥99%

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gln-Ser

Molecular Formula

C221H366N72O67S

Molecular Weight

5135.9 g/mol

Applications

Growth hormone regulation, fat metabolism research, cognitive and metabolic studies

Synthesis

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months.

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

Safety Information

Refer to provided MSDS

There are no reviews yet.

We value your feedback. Please leave a review below:

Research Procurement Information

Buy Tesamorelin Online for Research | COA Guide

Researchers searching for buy Tesamorelin online should evaluate Tesamorelin as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, Tesamorelin COA review, purity documentation, batch-specific documentation, lot traceability, product labeling, and storage information. This guide explains how qualified researchers can evaluate Tesamorelin for controlled research procurement through Pure Lab Peptides.

Fast Answer: Buy Tesamorelin Online for Laboratory Research

Researchers can buy Tesamorelin online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.

What Does “Buy Tesamorelin Online” Mean in a Research Context?

The phrase buy Tesamorelin online is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the search phrase refers to the documentation review process that qualified researchers, laboratory buyers, research institutions, and technical procurement teams use when evaluating an RUO peptide research material.

Research procurement is different from consumer purchasing. A laboratory buyer is not evaluating Tesamorelin for self-directed use, clinical use, veterinary use, therapeutic use, or diagnostic use. Instead, the procurement question is whether the material is clearly labeled for research use only, whether the product name and lot number match the available documentation, whether the batch-specific COA supports the stated purity and identity, and whether supplier language remains within RUO boundaries.

For an RUO peptide such as Tesamorelin, supplier evaluation should prioritize transparent documentation. That includes the Tesamorelin COA, purity documentation, identity testing, product form, storage information, and lot-level traceability. Researchers should also evaluate whether the supplier avoids dosing, administration, therapeutic, or personal-use language. Commercial search intent can be addressed safely only when the buying decision is framed as controlled laboratory procurement.

Tesamorelin Research Material Overview

Tesamorelin is a peptide research material associated with growth hormone-releasing hormone pathway literature and related secretagogue receptor research. Analytical database records identify Tesamorelin by molecular structure and formula, while regulated labeling sources describe tesamorelin as a synthetic analog of human growth hormone-releasing factor with a modified N-terminal structure [1] [2]. These identity details are useful for research documentation, but they do not convert an RUO material into a clinical, diagnostic, or therapeutic product.

Public compound databases and pharmacology references classify Tesamorelin as a peptide and identify it in relation to growth hormone-releasing hormone receptor research [3] [4]. Gene and protein database records identify the GHRH receptor as a receptor involved in GHRH signaling and related endocrine pathway biology [5] [6]. KEGG also lists tesamorelin acetate in a receptor-target context [7].

For RUO procurement, those scientific records are best used as identity and category context. Researchers may review molecular formula, sequence-related descriptions, compound class, and receptor-pathway references as part of a documentation file. They should not treat published pharmacology or pathway context as product-use guidance. Pathway relevance in published literature does not establish product-use guidance for RUO materials.

Why Researchers Search “Buy Tesamorelin Online”

Researchers search “buy Tesamorelin online” to compare research supplier documentation, not to obtain personal-use guidance. A qualified procurement team may need to confirm whether a Tesamorelin research material is available in a documented product form, whether the supplier provides an available batch-specific COA, and whether analytical documentation supports the stated compound identity and purity.

When technical buyers search to buy Tesamorelin, the most relevant questions are documentation-centered. Does the supplier identify the material as research-use-only? Does the Tesamorelin supplier documentation include lot-level traceability? Does the product page describe the form of the material, such as lyophilized powder? Does the COA align with the product label? Does the supplier avoid unsupported human-use, animal-use, therapeutic, diagnostic, or consumer claims?

Research procurement teams should also look at operational fit. A laboratory may need a research compound that can be documented in internal records, linked to a specific lot, and reviewed alongside analytical data. The product page, COA, purity documentation, identity testing information, and storage guidance should create a consistent record. That is the RUO-safe meaning of commercial search intent for this topic.

Research Procurement Checklist for Tesamorelin

  • Verify that Tesamorelin is labeled for research use only and is not presented for human, animal, clinical, diagnostic, or veterinary use.
  • Review the available batch-specific certificate of analysis before procurement.
  • Confirm that the Tesamorelin COA includes identity and purity documentation relevant to the listed material.
  • Check whether HPLC, LC-MS, mass spectrometry, or another analytical method is listed in the documentation.
  • Compare the product name, amount, lot number, and documentation for consistency across the product page, label, and COA.
  • Assess whether the supplier avoids dosing, administration, therapeutic, personal-use, or consumer-result claims.
  • Document storage and handling information in laboratory procurement records.
  • Evaluate whether the lyophilized powder form matches the needs of the controlled research workflow.
  • Confirm that the product is not marketed for human or animal consumption.

Tesamorelin Quality Signals to Review Before Buying Online

Before researchers buy Tesamorelin online for laboratory research, quality review should focus on documentation consistency rather than promotional claims. Strong RUO procurement signals include clear research-use-only labeling, available batch-specific COA documentation, Tesamorelin purity documentation, Tesamorelin identity testing, lot traceability, product form clarity, storage information, and supplier language that stays within laboratory-research boundaries.

Evaluation Area What Researchers Should Review Why It Matters for RUO Procurement
RUO labeling Confirm the product is clearly labeled for research use only Helps separate research procurement from human-use positioning
COA availability Review the available batch-specific certificate of analysis Supports lot-level documentation and quality review
Purity data Look for analytical support for the stated purity Helps evaluate material consistency
Identity testing Review HPLC, LC-MS, mass spectrometry, or related identity data in the documentation Helps confirm the material matches the listed compound
Lot traceability Match lot numbers across product and documentation Supports research recordkeeping
Product form Confirm whether the material is supplied as lyophilized powder or another documented form Supports laboratory planning
Storage information Review storage and handling documentation Helps maintain material integrity in laboratory settings
Supplier language Confirm the supplier avoids dosing, therapeutic, or personal-use claims Supports research-use-only positioning

COA, Purity, and Identity Documentation

A Tesamorelin COA should be read as part of a documentation package, not as a standalone marketing claim. Researchers should look for the compound name, lot number, test date, purity percentage, testing method, identity confirmation, molecular weight where relevant, chromatogram or mass data where available, product form, storage information, and consistency between the product page and batch-specific documentation.

A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. FDA RUO labeling guidance and FDA labeling resources are written for specific regulated contexts, but they illustrate the importance of intended-use clarity and documentation discipline in laboratory environments [8] [9]. ICH quality and analytical validation guidance also emphasizes identity, supplier documentation, and validation concepts in regulated quality systems [10] [11].

For peptide characterization, HPLC is widely used for peptide separation and purity review, while LC-MS, mass spectrometry, amino acid analysis, quantitative methods, and NMR-based approaches may support identity or content characterization depending on the documentation package [12] [13] [14] [15] [16]. For RUO procurement, the practical question is whether the available Tesamorelin purity documentation and identity testing support the laboratory record.

flowchart TD A[Receive product and COA] --> B{RUO labeling present?} B -- No --> C[Flag procurement gap] B -- Yes --> D{Lot number matches across label and COA?} D -- No --> E[Request batch-specific documentation] D -- Yes --> F{Identity supported by analytical method?} F -- No --> G[Request HPLC, LC-MS, or equivalent] F -- Yes --> H[Proceed to laboratory documentation and storage]

Research Literature Context

Published literature on Tesamorelin includes compound database records, receptor-pathway resources, review articles, and clinical studies outside the scope of RUO product use. Researchers should separate these literature categories carefully. Database and pharmacology resources can support identity, classification, and receptor-context review [1] [3] [4]. Analytical literature can support method awareness for purity and identity documentation [12] [16].

Several peer-reviewed reviews discuss Tesamorelin in regulated medical or investigational literature contexts [17] [18] [19] [20]. Randomized clinical studies have also examined tesamorelin in non-RUO settings [21] [22] [23] [24]. Published clinical literature should not be interpreted as use guidance for RUO materials.

For this procurement guide, the literature is used only to describe scientific context, classification, and documentation relevance. It does not provide instructions for use, preparation, administration, dosing, clinical application, veterinary application, or personal decision-making. Researchers evaluating a Tesamorelin research material should treat published literature as background context and evaluate the actual RUO material through labeling, COA, identity data, purity documentation, lot traceability, and supplier transparency.

Evidence Landscape

The Tesamorelin evidence landscape is mixed across database, analytical, receptor-pathway, review, and clinical literature categories. RUO procurement teams should use the evidence conservatively. A database entry can support identity review, an analytical method paper can support documentation literacy, and a clinical paper can show that literature exists outside RUO procurement. None of those sources creates product-use guidance for a research-use-only material.

Research Area What Literature Examines Evidence Type RUO Interpretation
Compound identity Molecular structure, formula, peptide classification, and database identifiers Database / analytical Supports identification, not product-use claims
Pathway or category context Growth hormone-releasing hormone receptor pathway literature and receptor classification Database / review / preclinical context Useful for research context, not therapeutic claims
Analytical testing Purity, identity, and batch verification concepts for peptide materials HPLC / LC-MS / mass spectrometry / COA Supports documentation review
Storage and stability Material form, label consistency, and handling considerations Laboratory documentation Supports research workflow planning
Clinical literature Studies conducted outside the scope of RUO material procurement Clinical / review Should not be interpreted as RUO product-use guidance

Claim Boundary Table

Commercial search language should be handled with precise RUO boundaries. The goal is to help qualified researchers review Tesamorelin supplier documentation without implying personal use, clinical use, animal use, therapeutic outcomes, or protocol guidance.

Research-Safe Statement Why It Is Acceptable Non-Compliant Version to Avoid
“Tesamorelin is discussed in published research related to GHRH pathway and receptor-context literature.” Describes literature context without making a product claim “Tesamorelin creates a human outcome.”
“Researchers should review COA and identity data before procurement.” Focuses on documentation and quality review “Users should buy Tesamorelin for results.”
“Pure Lab Peptides supplies Tesamorelin as a research-use-only material.” Clarifies intended use “Pure Lab Peptides supplies Tesamorelin for therapy.”
“The phrase buy Tesamorelin online is addressed as research procurement intent.” Qualifies commercial search intent “Buy Tesamorelin online for personal use.”
“Tesamorelin purity documentation and identity testing should be reviewed together.” Emphasizes analytical documentation rather than expected outcomes “Purity alone proves everything needed for use.”

How Pure Lab Peptides Presents Tesamorelin

Pure Lab Peptides presents Tesamorelin 10mg as a research-use-only laboratory material. The product is supplied as lyophilized powder, carries a ≥99% purity claim, and has an available batch-specific COA for documentation review. Researchers should review the product page, COA, purity information, identity documentation, storage and handling information, and lot-level traceability before selecting any RUO research material.

Review the Pure Lab Peptides Tesamorelin research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. Researchers comparing broader peptide research materials can also review the research peptide collection, the Pure Lab Peptides blog, and shipping and returns information for supplier transparency and procurement planning.

Pure Lab Peptides documentation should be assessed as part of a controlled laboratory procurement workflow. Technical buyers should match the product name, amount, lot number, and COA; confirm the lyophilized powder form; record storage information; and maintain internal records for the research material. This documentation-centered approach supports supplier evaluation without converting the material into a consumer product or therapeutic offering.

Common Misunderstandings About Buying Tesamorelin Online

Misunderstanding: “Buy Tesamorelin online” means personal use

Buy Tesamorelin online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, storage details, and supplier transparency.

Misunderstanding: Published literature equals product-use guidance

Published literature may describe Tesamorelin identity, receptor context, analytical methods, or studies conducted outside RUO procurement. That literature should not be converted into instructions for using an RUO material. Pathway relevance in published literature does not establish product-use guidance for RUO materials.

Misunderstanding: Purity percentage alone proves identity

A stated purity percentage is important, but it is not the whole documentation package. Researchers should evaluate Tesamorelin purity documentation alongside identity testing, analytical method information, lot number consistency, product form, storage guidance, and supplier documentation.

Misunderstanding: COA documentation does not need to be batch-specific

Batch-specific COA review matters because research records should connect the material received to the lot-specific documentation. Procurement teams should match the lot number on the product label with the lot number on the COA and retain the documentation in internal laboratory records.

Misunderstanding: RUO labeling supports human or animal use

RUO labeling does not support human use, animal use, clinical use, veterinary use, diagnostic use, or consumer use. For Tesamorelin research-use-only procurement, the label and supplier language should keep the material within controlled laboratory research boundaries.

Misunderstanding: Supplier claims can replace analytical documentation

Supplier language should never replace the documentation review process. Researchers should prioritize batch-specific COA access, Tesamorelin identity testing, purity documentation, storage information, lot-level traceability, and clear RUO positioning over promotional descriptions or unsupported claims.

FAQs About Buying Tesamorelin Online for Research

Where can researchers buy Tesamorelin online for laboratory research?

Researchers can buy Tesamorelin online for laboratory research from an RUO supplier that provides clear research-use-only labeling, available batch-specific COA documentation, purity information, identity documentation, storage guidance, and supplier transparency. Pure Lab Peptides provides a Tesamorelin 10mg product page for qualified research procurement review.

What should researchers check before buying Tesamorelin online?

Before buying Tesamorelin online, researchers should check RUO labeling, product name consistency, available batch-specific COA documentation, purity data, identity testing, lot number matching, lyophilized powder form, storage information, and supplier language. The supplier should avoid dosing, administration, therapeutic, diagnostic, animal-use, and personal-use claims.

Why does a COA matter when buying Tesamorelin?

A Tesamorelin COA matters because it gives researchers a batch-specific documentation record to review before procurement. The COA should be evaluated with the product label, lot number, identity data, purity documentation, testing method, and storage information. A COA supports documentation review; it does not create product-use guidance.

Is Tesamorelin intended for human or animal consumption?

Tesamorelin research-use-only material is not intended for human or animal consumption. In this article, Tesamorelin is discussed only as a laboratory research material for qualified researchers and technical procurement teams. The content does not provide clinical, veterinary, diagnostic, therapeutic, dosing, administration, or personal-use guidance.

What does research use only mean for Tesamorelin?

Research use only means Tesamorelin is positioned for controlled laboratory research and documentation review, not for human use, animal use, diagnosis, treatment, or consumer application. Researchers should evaluate RUO labeling, supplier documentation, purity information, identity testing, lot traceability, and storage guidance before selecting a research material.

How should published literature about Tesamorelin be interpreted?

Published literature about Tesamorelin should be interpreted as scientific context, not as RUO product-use guidance. Database entries, receptor-pathway sources, analytical method papers, review articles, and clinical studies can inform research background. They should not be used to infer instructions, expected outcomes, protocols, or consumer applications for RUO materials.

Next Steps

Qualified researchers evaluating Tesamorelin should review product labeling, COA status, identity documentation, purity information, storage guidance, and supplier transparency. Review the Tesamorelin product page for RUO labeling, purity information, and available batch-specific documentation before selecting any research-use-only material.

References

  1. National Center for Biotechnology Information. “PubChem Compound Summary for CID 16137828, Tesamorelin.” PubChem. 2026. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin
  2. National Library of Medicine. “DailyMed – EGRIFTA SV – tesamorelin kit.” DailyMed. Revised 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d783378-b02d-4f19-99dd-0fc91a042224
  3. EMBL-EBI. “TESAMORELIN: CHEMBL1237026.” ChEMBL. 2026. https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1237026
  4. International Union of Basic and Clinical Pharmacology. “Tesamorelin ligand record.” IUPHAR/BPS Guide to Pharmacology. 2026. https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6959&tab=structure
  5. National Center for Biotechnology Information. “GHRHR growth hormone releasing hormone receptor.” NCBI Gene. 2026. https://www.ncbi.nlm.nih.gov/gene/2692
  6. UniProt Consortium. “Somatoliberin receptor: Q02643.” UniProtKB. 2026. https://www.uniprot.org/uniprotkb/Q02643/entry
  7. Kyoto Encyclopedia of Genes and Genomes. “Tesamorelin acetate: D09015.” KEGG Drug. 2026. https://www.genome.jp/dbget-bin/www_bget?drug:D09015
  8. U.S. Food and Drug Administration. “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only.” FDA Guidance Document. 2013. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/distribution-in-vitro-diagnostic-products-labeled-research-use-only-or-investigational-use-only
  9. U.S. Food and Drug Administration. “In Vitro Diagnostic Device Labeling Requirements.” FDA Medical Devices. 2024. https://www.fda.gov/medical-devices/device-labeling/in-vitro-diagnostic-device-labeling-requirements
  10. U.S. Food and Drug Administration. “Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients.” FDA Guidance Document. 2016. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q7-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients-guidance-industry
  11. U.S. Food and Drug Administration. “Q2(R2) Validation of Analytical Procedures.” FDA Guidance Document. 2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q2r2-validation-analytical-procedures
  12. Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS. “HPLC Analysis and Purification of Peptides.” Methods in Molecular Biology. 2007. https://pubmed.ncbi.nlm.nih.gov/18604941/
  13. Li C, Bhavaraju S, et al. “Survey of Peptide Quantification Methods and Comparison of Their Reproducibility: A Case Study Using Oxytocin.” Journal of Pharmaceutical and Biomedical Analysis. 2019. https://pubmed.ncbi.nlm.nih.gov/30640042/
  14. McCarthy D, Han Y, Carrick K, Schmidt D, Workman W, Matejtschuk P, Duru C, Atouf F. “Reference Standards to Support Quality of Synthetic Peptide Therapeutics.” Pharmaceutical Research. 2023. https://pubmed.ncbi.nlm.nih.gov/36949371/
  15. Choules MP, Bisson J, Gao W, Lankin DC, McAlpine JB, Niemitz M, Jaki BU, Franzblau SG, Pauli GF. “Quality Control of Therapeutic Peptides by 1H NMR HiFSA Sequencing.” The Journal of Organic Chemistry. 2019. https://pubmed.ncbi.nlm.nih.gov/30793905/
  16. Kuril AK, et al. “Analytical Considerations for Characterization of Generic Peptide Product: A Regulatory Insight.” Pharmaceutical Research. 2024. https://pubmed.ncbi.nlm.nih.gov/39089363/
  17. Wang Y, Tomlinson B. “Tesamorelin, a Human Growth Hormone Releasing Factor Analogue.” Expert Opinion on Investigational Drugs. 2009. https://pubmed.ncbi.nlm.nih.gov/19243281/
  18. Dhillon S. “Tesamorelin: A Review of Its Use in the Management of HIV-Associated Lipodystrophy.” Drugs. 2011. https://pubmed.ncbi.nlm.nih.gov/21668043/
  19. Spooner LM. “Tesamorelin: A Growth Hormone-Releasing Factor Analogue for HIV-Associated Lipodystrophy.” The Annals of Pharmacotherapy. 2012. https://pubmed.ncbi.nlm.nih.gov/22298602/
  20. Bedimo R. “Growth Hormone and Tesamorelin in the Management of HIV-Associated Lipodystrophy.” HIV/AIDS – Research and Palliative Care. 2011. https://pmc.ncbi.nlm.nih.gov/articles/PMC3218714/
  21. Falutz J, Potvin D, Mamputu JC, Assaad H, Zoltowska M, Michaud SE, Berger D, Somero M, Moyle G, Brown S, Martorell C, Turner R, Grinspoon S. “Effects of Tesamorelin, a Growth Hormone-Releasing Factor, in HIV-Infected Patients with Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial with a Safety Extension.” Journal of Acquired Immune Deficiency Syndromes. 2010. https://pubmed.ncbi.nlm.nih.gov/20101189/
  22. Stanley TL, et al. “Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients with Abdominal Fat Accumulation: A Randomized Clinical Trial.” JAMA. 2014. https://pubmed.ncbi.nlm.nih.gov/25038357/
  23. Stanley TL, et al. “Effects of Tesamorelin on Non-Alcoholic Fatty Liver Disease in HIV: A Randomised, Double-Blind, Multicentre Trial.” The Lancet HIV. 2019. https://pubmed.ncbi.nlm.nih.gov/31611038/
  24. Clemmons DR, Miller S, Mamputu JC. “Safety and Metabolic Effects of Tesamorelin, a Growth Hormone-Releasing Factor Analogue, in Patients with Type 2 Diabetes: A Randomized, Placebo-Controlled Trial.” PLOS ONE. 2017. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179538

Have Questions?

Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.

Pure Lab Peptides Logo with Black Letters
0